The epidemiology of lung cancer
Gillissen, A.
MMW Fortschritte der Medizin 148(22): 24-25
2006
ISSN/ISBN: 1438-3276 PMID: 16821575 Document Number: 599679
Among the various forms of cancer, that affecting the lung has one of the most unfavorable prognoses. While the numbers of newly diagnosed cases and mortality rates among women are currently on the increase, the number of men diagnosed with lung cancer has been decreasing in past years. In comparison with other European countries, its incidence in Germany is in the middle third for men, but in the upper third for women.
Document emailed within 1 workday
Related Documents
Percy, C.; Sobin, L. 1983: Surveillance, epidemiology, and end results lung cancer data applied to the World Health Organization's classifications of lung tumors Journal of the National Cancer Institute 70(4): 663-666Voicu-Măceşeanu, A.; Nitu, M.; Olteanu, M.; Bică, D. 2007: Epidemiology of lung cancer Pneumologia 56(2): 78-84
Merveilleux du Vignaux, C.; Beaucaire-Danel, S.; Girard, N. 2017: Lung cancer: epidemiology and screening La Revue du Praticien 67(1): 34-39
Frusch, N.; Bosquée, L.; Louis, R. 2007: Lung cancer. Epidemiology and etiologic factors Revue Medicale de Liege 62(9): 548-553
Jahn, I.; Jöckel, K.H.; Ahrens, W.; Drescher, K.; Müller, K.M.; Witzko, K.H. 1990: Results of the epidemiology of lung cancer in females Pneumologie 44(1): 14-23
Shimizu, H. 1994: Recent trends in lung cancer epidemiology Nihon Kyobu Shikkan Gakkai Zasshi 32 Suppl: 183-186
Martini, B. 2006: Lung cancer--epidemiology, prognosis and therapy Medizinische Monatsschrift für Pharmazeuten 29(6): 217-221
Fajraoui, N.; Charfi, M.R.; Khouani, H.; Annabi, H.; Bouhaouala, M.H.; Boussen, H.; Kilani, T. 2007: Clinical epidemiology of primary lung cancer in Tunisia. 100 cases La Tunisie Medicale 85(9): 766-772
Abulfateh, N.Mohamed.; Hamadeh, R.R.; Fikree, M. 2018: Lung cancer epidemiology among the Bahraini population, 1998-2011 Gulf journal of oncology 1(26): 18-22
Sharp, L.; Brewster, D. 1999: The epidemiology of lung cancer in Scotland: a review of trends in incidence, survival and mortality and prospects for prevention Health Bulletin 57(5): 318-331
Hillerdal, G. 1999: Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer Lakartidningen 96(43): 4691
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
McCormack, V.A.; Hung, R.J.; Brenner, D.R.; Bickeböller, H.; Rosenberger, A.; Muscat, J.E.; Lazarus, P.; Tjønneland, A.; Friis, Søren.; Christiani, D.C.; Chun, E-Mi.; Le Marchand, L.; Rennert, G.; Rennert, H.S.; Andrew, A.S.; Orlow, I.; Park, B.; Boffetta, P.; Duell, E.J. 2011: Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO) Cancer Causes and Control: Ccc 22(12): 1709-1720
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
El-Akawi, Z.J.; Nusier, M.K.; Zoughool, F.E. 2006: Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients Saudi Medical Journal 27(2): 181-184
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
O'Rourke, M.A.; Feussner, J.R.; Feigl, P.; Laszlo, J. 1987: Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly JAMA 258(7): 921-926
Hijmering-Kappelle, L.B.M.; van der Wekken, A.J.; Hiltermann, T.J.N.; Groen, H.J.M. 2017: New biopsy at lung cancer progression: rational treatment of resistant lung cancer Nederlands Tijdschrift Voor Geneeskunde 161: D1229
Schreiber, G.; Pitterle, D.; Kim, Y.C.; Bepler, G. 1999: Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung Anticancer Research 19(2a): 1109-1115